After ending yesterday's choppy session narrowly mixed, stocks moved to the upside in early trading on Wednesday but quickly came under pressure. The major averages pulled back well off their highs of the session and firmly into negative territory.The major averages saw further downside going into the end of the day, closing just off their lows of the session.The tech-heavy Nasdaq tumbled 418.14 points or 1.8 percent to 22,693.32, the S&P 500 slumped 78.83 points or 1.2 percent to 6,721.43 and the Dow slid ...

NEW YORK, Dec. 17, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Skye Bioscience, Inc. (NASDAQ: SKYE). Shareholders who purchased shares of SKYE during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/skye-bioscience-inc-loss-submission-form/?id=180541&from=3 CLASS PERIOD: Nov ...

AbbVie and several other drugmakers are expected to announce on Friday agreements with the U.S. government to lower certain prescription drug prices and meet other demands made by President Donald Tru... ...

NEW YORK, Dec. 17, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Inspire Medical Systems, Inc. (NYSE: INSP). Shareholders who purchased shares of INSP during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/inspire-medical-systems-inc-loss-submission-form/?id=180537&from=3 CLA ...

NEW YORK, Dec. 17, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Freeport-McMoRan Inc. (NYSE: FCX). Shareholders who purchased shares of FCX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/freeport-mcmoran-inc-loss-submission-form/?id=180538&from=3 CLASS PERIOD: Februa ...

NEW YORK, Dec. 17, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Synopsys, Inc. (NASDAQ: SNPS). Shareholders who purchased shares of SNPS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/synopsys-inc-loss-submission-form/?id=180539&from=3 CLASS PERIOD: December 4, 2024 ...

So what is the thesis of one about this discovery is why the $30 Paramount is not living up to what's been offered elsewhere. So what Warner Brothers is saying is they reviewed the Paramount $30 a share offer. It's the same offer that Paramount had offered them two weeks ago when the board already deliberated and decided to go with Netflix.And in some ways, they're saying this offer, the tender offer, is worse than what was initially offered. The logic is they don't view it as certain as the deal they alrea ...

NEW YORK, Dec. 17, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of CarMax, Inc. (NYSE: KMX). Shareholders who purchased shares of KMX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/carmax-inc-loss-submission-form/?id=180536&from=3 CLASS PERIOD: June 20, 2025 to November ...

BRANFORD, Conn., Dec. 17, 2025 /PRNewswire/ -- Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today announced it received a notice from the staff of NYSE American LLC (the "Exchange") approving Azitra's plan (the "Plan") to come into compliance with the Exchange's continued listing standards under Section 1003(a)(ii) of the NYSE American Company Guide. As previously reported, on October 1, 2025, Azitra rec ...

This new agreement brings the total deal value of the QuantumBasel and IonQ partnership to over $60 million and extends IonQ's on-site presence in Switzerland four more years, continuing through 2029. QuantumBasel is IonQ's official Innovation Center in Europe, serving as a hub for European industry, academia, and research institutions to explore practical quantum computing applications and access IonQ's latest enterprise-grade systems. "Our extended partnership with QuantumBasel represents a cornerstone of ...